BLTE · earnings call history
Belite Bio Q2 FY26 — Tinlarebant NDA Accepted with Priority Review
Read the briefBelite Bio Q1 FY26 — NDA Rolling Submission Initiated & Strong Cash Position
Read the briefBelite Bio Q4 FY25 — Positive Phase III Stargardt Results & NDA Prep
Read the briefBrowse all US companies on the earnings-call register.